tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Neurizon Therapeutics Reschedules 2025 AGM to Enhance Shareholder Engagement
Company AnnouncementsNeurizon Therapeutics Reschedules 2025 AGM to Enhance Shareholder Engagement
9d ago
Neurizon Therapeutics to Present Q4 Updates and Strategic Initiatives
PremiumCompany Announcements
Neurizon Therapeutics to Present Q4 Updates and Strategic Initiatives
15d ago
Neurizon Therapeutics Releases Corporate Governance Statement
PremiumCompany Announcements
Neurizon Therapeutics Releases Corporate Governance Statement
15d ago
Neurizon Therapeutics Reports Increased Financial Losses for 2025
PremiumCompany Announcements
Neurizon Therapeutics Reports Increased Financial Losses for 2025
15d ago
Neurizon Therapeutics to Host Shareholder Webinar on ALS Treatment Developments
PremiumCompany Announcements
Neurizon Therapeutics to Host Shareholder Webinar on ALS Treatment Developments
21d ago
Neurizon Therapeutics Reports Positive Long-Term Results for ALS Treatment
PremiumCompany AnnouncementsNeurizon Therapeutics Reports Positive Long-Term Results for ALS Treatment
21d ago
Neurizon Faces FDA Review Delay for ALS Therapy NUZ-001
Premium
Company Announcements
Neurizon Faces FDA Review Delay for ALS Therapy NUZ-001
26d ago
Neurizon Therapeutics Advances NUZ-001 Manufacturing for ALS Treatment
Premium
Company Announcements
Neurizon Therapeutics Advances NUZ-001 Manufacturing for ALS Treatment
29d ago
Neurizon Therapeutics Sets Date for AGM and Director Nominations
PremiumCompany Announcements
Neurizon Therapeutics Sets Date for AGM and Director Nominations
1M ago
Neurizon Therapeutics Advances NUZ-001 Development and Secures Key Partnerships
PremiumCompany Announcements
Neurizon Therapeutics Advances NUZ-001 Development and Secures Key Partnerships
1M ago
Neurizon Secures $1.5M Loan Against Future R&D Tax Rebate
PremiumCompany Announcements
Neurizon Secures $1.5M Loan Against Future R&D Tax Rebate
1M ago
Neurizon Therapeutics Advances ALS Drug with FDA Submission
PremiumCompany Announcements
Neurizon Therapeutics Advances ALS Drug with FDA Submission
2M ago
Neurizon Therapeutics Advances Towards Lifting FDA Hold on ALS Treatment
PremiumCompany AnnouncementsNeurizon Therapeutics Advances Towards Lifting FDA Hold on ALS Treatment
2M ago
Neurizon Therapeutics Secures Global Licensing Agreement with Elanco
Premium
Company Announcements
Neurizon Therapeutics Secures Global Licensing Agreement with Elanco
2M ago
Neurizon Therapeutics Announces Licensing Agreement and Upcoming Shareholder Webinar
Premium
Company Announcements
Neurizon Therapeutics Announces Licensing Agreement and Upcoming Shareholder Webinar
2M ago
Neurizon Therapeutics Secures Global License with Elanco to Advance Neurodegenerative Treatment
PremiumCompany Announcements
Neurizon Therapeutics Secures Global License with Elanco to Advance Neurodegenerative Treatment
2M ago
Neurizon Therapeutics Issues Unquoted Equity Securities
PremiumCompany Announcements
Neurizon Therapeutics Issues Unquoted Equity Securities
3M ago
Neurizon Therapeutics Unveils Liquid Formulation of NUZ-001 for ALS
PremiumCompany Announcements
Neurizon Therapeutics Unveils Liquid Formulation of NUZ-001 for ALS
3M ago
Neurizon Therapeutics’ NUZ-001 Shows Promising Blood-Brain Barrier Penetration
PremiumCompany Announcements
Neurizon Therapeutics’ NUZ-001 Shows Promising Blood-Brain Barrier Penetration
3M ago
Neurizon Therapeutics to Release Shares from Escrow
PremiumCompany AnnouncementsNeurizon Therapeutics to Release Shares from Escrow
3M ago
Neurizon Therapeutics Relocates Headquarters to Enhance Operations
Premium
Company Announcements
Neurizon Therapeutics Relocates Headquarters to Enhance Operations
3M ago
Neurizon Therapeutics to Present Promising ALS Treatment Findings at Global Summit
Premium
Company Announcements
Neurizon Therapeutics to Present Promising ALS Treatment Findings at Global Summit
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >